The United States has launched an investigation into Germany's pharmaceutical pricing policies to determine whether they unfairly disadvantage American companies and restrict U.S. commerce.
U.S. Trade Representative Jamieson Greer said the probe would examine whether Germany's so-called “persistent underpayment” for innovative medicines is unreasonable or discriminatory.
The investigation, launched under Section 301 of the Trade Act of 1974, follows months of discussions between Washington and Berlin, according to Greer.
Greer said President Donald Trump believes American patients should not shoulder a disproportionate share of global pharmaceutical research and development costs.
He also criticized reports that Germany is considering measures that could further reduce spending on innovative medicines, calling it a "serious step backwards."
Germany is pursuing healthcare reforms aimed at lowering insurance costs and saving more than €16 billion in healthcare spending.
The move comes amid longstanding criticism of high prescription drug prices in the United States. A 2024 RAND Corporation study found U.S. prescription drug prices were nearly three times higher than those in 33 other countries.
Supporters of Germany’s pricing system argue the policies are designed to keep medicines affordable and control healthcare spending, while Washington says trading partners should contribute more to funding pharmaceutical innovation.
The preliminary results of an investigation into Kazakhstan's armed forces have emerged. The probe was ordered by President ...
Russia struck Ukraine overnight in one of the biggest attacks of the conflict, killing at least 19 people, Kyiv's Foreign Minist...
An investigation into August Hanning, the former head of Germany’s Federal Intelligence Service (BND), has no connection to Azerbaijan,...
Russia's health watchdog said on Tuesday that no cases of plague had been detected among anyone who had come into contact with a Siberian plague institute laboratory worker who died last week, and locals said their lives had barely been disrupted.
An Azerbaijani citizen died and another is missing after a cargo ship was attacked by a drone in the Black Sea, near the coast of Romania on Monday, 5 October, Baku's Foreign Ministry has said.
A large Ukrainian drone attack on Moscow and the surrounding region has killed two people, damaged homes and sparked a major fire at a key fuel facility, according to Russian officials and military bloggers.
Russia struck Ukraine overnight in one of the biggest attacks of the conflict, killing at least 19 people, Kyiv's Foreign Ministry said on Wednesday. Around 70 missiles were fired at Ukraine during the attack, as well as drones, the Ministry said.
The German-Azerbaijani Connectivity Conference 2026 commenced on 6 October in Baku under the title “Mobilising Finance for Infrastructure, Transport, Logistics, Green Energy, and Digitalisation along the Middle Corridor.”
Health advice now reaches people through social media, fitness apps, wearable technology and AI. From detoxes and protein-focused diets to skincare and fitness trends, online wellness content is shaping everyday health choices while raising concerns about misinformation and potential risks.
Global cholera deaths reached their highest annual level in more than 20 years in 2025, despite a decline in reported cases, according to the World Health Organization (WHO).
Chinese researchers have developed the world’s smallest CT scanner, a portable device designed to produce images of tiny fossils and archaeological relics.
Here's your AnewZ Daily Brief for 17 September 2026. These are the top five stories making headlines in the field of health.
Doctors in St. Louis have successfully separated Ethiopian two-year-old twin girls who were born joined at the head after a months-long series of complex operations culminating in a nearly 25-hour final procedure, doctors said on Wednesday.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment